Tissue Inhibitor of Metalloproteinase-1 Inhibits Apoptosis of Rat and Human Hepatic Stellate Cells In Vitro

Tissue Inhibitor of Metalloproteinase-1 Inhibits Apoptosis of Rat and Human Hepatic Stellate Cells In Vitro

Saved in:

Bibliographic Details
Main Authors:	Frank R. Murphy, Razao Issa, Christopher Benyon, John P. Iredale
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/tsw.2001.220
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
by: Ikuo Nakamura, et al.
Published: (2014-01-01)

The role of matrix metalloproteinase-9 and the tissue inhibitor of metalloproteinase — 1 in endogenous uveitis in children
by: M. A. Khrabrova, et al.
Published: (2024-03-01)

Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway
by: Bingge Fan, et al.
Published: (2025-04-01)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
by: Ewa Robak, et al.
Published: (2006-01-01)

Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1
by: Pallavi S. Ghodpage, et al.
Published: (2014-10-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer
by: Arunee Dechaphunkul, et al.
Published: (2012-01-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Spinal cord injury induces transient activation of hepatic stellate cells in rat liver
by: Inmaculada Fernandez-Canadas, et al.
Published: (2025-01-01)

Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse
by: Ann Kristin Barton, et al.
Published: (2015-01-01)

The Imbalance Between Metalloproteinases and Their Tissue Inhibitors Is Involved in the Pathogenesis of Dermatitis Herpetiformis
by: Agnieszka Zebrowska, et al.
Published: (2005-01-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

Comparison of microcurrent and low level laser therapy on matrix metalloproteinases and tissue inhibitors of metalloproteinases expressions in surgical wound healing
by: Ayman Mohammed El Makakey, et al.
Published: (2025-08-01)

Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
by: Sheng Liqin, et al.
Published: (2025-08-01)

The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
by: Qian Ding, et al.
Published: (2019-01-01)

Hepatocyte-derived liver progenitor-like cells attenuate liver cirrhosis via induction of apoptosis in hepatic stellate cells
by: Xu Zhou, et al.
Published: (2025-02-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

THE ROLE OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN THE DEVELOPMENT OF COMPLICATIONS OF KIDNEY DISEASE IN CHILDREN
by: G. A. Sukhanova, et al.
Published: (2015-06-01)

Role of integrin α4 in the inhibition of fibrosis in activated hepatic stellate cells by Periplaneta americana extract
by: Ying Fang, et al.
Published: (2025-03-01)

Aquaporin-7 Deficiency Attenuates Liver Fibrosis by Inhibiting the Activation and Proliferation of Hepatic Stellate CellsSummary
by: Junqi Zhang, et al.
Published: (2025-01-01)

Isolation and Time Lapse Microscopy of Highly Pure Hepatic Stellate Cells
by: Matthias Bartneck, et al.
Published: (2015-01-01)

Paracrine Potential of the Human Adipose Tissue-Derived Stem Cells to Modulate Balance between Matrix Metalloproteinases and Their Inhibitors in the Osteoarthritic Cartilage In Vitro
by: Jaroslav Denkovskij, et al.
Published: (2017-01-01)

Inhibition of neutrophil migration by a selective inhibitor of matrix metalloproteinase: analysis by intravital microscopy
by: T. Oda, et al.
Published: (1995-01-01)

Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling
by: Dan Wang, et al.
Published: (2025-06-01)

Author Correction: The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
by: Qian Ding, et al.
Published: (2025-07-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis
by: Yunan Gao, et al.
Published: (2016-01-01)

Hepatic stellate cells and their role in the formation of the progenitor cell niche
by: V. V. Zhdanov, et al.
Published: (2024-04-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

The gene expression of caspase 3, matrix metalloproteinase-9, tissue inhibitor of metalloproteinases-1, and cathepsins S and K in patients with osteoarthritis requiring large joint replacement
by: E. V. Chetina, et al.
Published: (2020-05-01)

Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses
by: Sven Hector, et al.
Published: (2024-08-01)

Evaluation the tissue inhibitor of matrix metalloproteinases first type concentration in various platelet-related products
by: E. V. Chentsova, et al.
Published: (2024-12-01)

THE RELATIONSHIP BETWEEN THE EXPRESSION LEVELS OF TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) AND SEVERITY OF ATHEROSCLEROSIS
by: Gizem Çelebi, et al.
Published: (2021-09-01)

Micheliolide Alleviates Hepatic Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via the TrxR1/2-Mediated ROS/MEK/ERK Pathway
by: Yi Liu, et al.
Published: (2025-02-01)

Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients
by: Monika Zajkowska, et al.
Published: (2018-07-01)

Indole-3-propionic acid promotes hepatic stellate cells inactivation
by: Mariana Ilha, et al.
Published: (2025-03-01)

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01)

The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
by: K. V. Sirotkina, et al.
Published: (2023-09-01)